Renal failure due to combined cast nephropathy, amyloidosis and light-chain deposition disease

Nephrology Dialysis Transplantation

Volumn 25, Issue 4, 2010, Pages 1340-1343

  Lorenz, Elizabeth C ^a   Sethi, Sanjeev ^a   Poshusta, Tanya L ^b   Ramirez Alvarado, Marina ^b   Kumar, Shaji ^a   Lager, Donna J ^a   Fervenza, Fernando C ^a   Leung, Nelson ^a  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Amyloidosis; Light chain; Myeloma; Nephropathy

Indexed keywords

AMYLOID; AMYLOID P COMPONENT; BORTEZOMIB; COMPLEMENTARY DNA; CREATININE; DEXAMETHASONE; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; PROTEIN; THALIDOMIDE;

ACUTE KIDNEY TUBULE NECROSIS; ADULT; AMYLOIDOSIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW BIOPSY; CASE REPORT; COMBINED CAST NEPHROPATHY; CONCENTRATION (PARAMETERS); ELECTRON MICROSCOPY; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; IMMUNOFLUORESCENCE; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FAILURE; LIGHT CHAIN; LIGHT CHAIN DEPOSITION DISEASE; MULTIPLE MYELOMA; PERIODIC ACID SCHIFF STAIN; PLASMA CELL; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEIN ELECTROPHORESIS; PROTEIN URINE LEVEL; PROTEINURIA; TREATMENT RESPONSE;

ADULT; AMYLOIDOSIS; FEMALE; HUMANS; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULIN LIGHT CHAINS; KIDNEY DISEASES; KIDNEY FAILURE; MULTIPLE MYELOMA;

EID: 77950233020     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp735     Document Type: Article

References (20)

1. Lin J, Markowitz GS, Valeri AM, et al. Renal monoclonal immuno-globulin deposition disease: the disease spectrum. J Am Soc Nephrol 2001; 12: 1482-1492
2. Ivanyi B. Renal complications in multiple myeloma. Acta Morphol Hung 1989; 37: 235-243
3. Korbet SM, Schwartz MM. Multiple myeloma. J Am Soc Nephrol 2006; 17: 2533-2545
4. Dimopoulos MA, Kastritis E, Rosinol L, et al. Pathogenesis and treatment of renal failure in multiple myeloma. Leukemia 2008; 22: 1485-1493
5. Herrera GA. Renal lesions associated with plasma cell dyscrasias: practical approach to diagnosis, new concepts, and challenges. Arch Pathol Lab Med 2009; 133: 249-267
6. Markowitz GS. Dysproteinemia and the kidney. Adv Anat Pathol 2004; 11: 49-63
7. Obici L, Perfetti V, Palladini G, et al. Clinical aspects of systemic amyloid diseases. Biochim Biophys Acta 2005; 1753: 11-22
8. Leung N, Lager DJ, Gertz MA, et al. Long-term outcome of renal transplantation in light-chain deposition disease. Am J Kidney Dis 2004; 43: 147-153
9. Gokden N, Barlogie B, Liapis H. Morphologic heterogeneity of renal light-chain deposition disease. Ultrastruct Pathol 2008; 32: 17-24
10. Ronco PM, Aucouturier P. The molecular bases of plasma cell dyscrasia-related renal diseases. Nephrol Dial Transplant 1999; 14: 4-8
11. Solomon A, Weiss DT, Kattine AA. Nephrotoxic potential of Bence Jones proteins. N Engl J Med 1991; 324: 1845-1851
12. Dealwis C, Wall J. Towards understanding the structure-function relationship of human amyloid disease. Curr Drug Targets 2004; 5: 159-171
13. Kaplan B, Ramirez-Alvarado M, Sikkink L, et al. Free light chains in plasma of patients with light chain amyloidosis and non-amyloid light chain deposition disease. High proportion and heterogeneity of disul-fide-linked monoclonal free light chains as pathogenic features of amyloid disease. Br J Haematol 2009; 144: 705-715
14. Russell WJ, Cardelli J, Harris E, et al. Monoclonal light chain-mesangial cell interactions: early signaling events and subsequent pathologic effects. Lab Invest 2001; 81: 689-703
15. Keeling J, Teng J, Herrera GA. AL-amyloidosis and light-chain deposition disease light chains induce divergent phenotypic transformations of human mesangial cells. Lab Invest 2004; 84: 1322-1338
16. Teng J, Russell WJ, Gu X, et al. Different types of glomerulopathic light chains interact with mesangial cells using a common receptor but exhibit different intracellular trafficking patterns. Lab Invest 2004; 84: 440-451
17. Sethi S, Hanna MH, Fervenza FC. Unusual casts in a case of multiple myeloma. Am J Kidney Dis 2009; 54: 970-974
18. Buxbaum J, Gallo G. Nonamyloidotic monoclonal immunoglobulin deposition disease. Light-chain, heavy-chain, and light-and heavy-chain deposition diseases. Hematol Oncol Clin North Am 1999; 13: 1235-1248
19. Preud'Homme JL, Morel-Maroger L, Brouet JC, et al. Synthesis of abnormal heavy and light chains in multiple myeloma with visceral deposition of monoclonal immunoglobulin. Clin Exp Immunol 1980; 42: 545-553
20. Gokden N, Cetin N, Colakoglu N, et al. Morphologic manifestations of combined light-chain deposition disease and light-chain cast ne-phropathy. Ultrastruct Pathol 2007; 31: 141-149